{"id":"https://openalex.org/W4361945948","doi":"https://doi.org/10.1158/1078-0432.c.6525963","title":"Data from Administration of Hypoxia-Activated Prodrug Evofosfamide after Conventional Adjuvant Therapy Enhances Therapeutic Outcome and Targets Cancer-Initiating Cells in Preclinical Models of Colorectal Cancer","display_name":"Data from Administration of Hypoxia-Activated Prodrug Evofosfamide after Conventional Adjuvant Therapy Enhances Therapeutic Outcome and Targets Cancer-Initiating Cells in Preclinical Models of Colorectal Cancer","publication_year":2023,"publication_date":"2023-03-31","ids":{"openalex":"https://openalex.org/W4361945948","doi":"https://doi.org/10.1158/1078-0432.c.6525963"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.c.6525963","doi":"https://doi.org/10.1158/1078-0432.c.6525963","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1078-0432.c.6525963","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"http://dx.doi.org/10.1158/1078-0432.c.6525963","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5070383591","display_name":"Jennifer Haynes","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jennifer Haynes","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090391995","display_name":"Trevor D. McKee","orcid":"https://orcid.org/0000-0002-2195-6146","observed_orcids":["https://orcid.org/0000-0002-2195-6146"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Trevor D. McKee","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065029494","display_name":"Andrew Haller","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Andrew Haller","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Yadong Wang","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yadong Wang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Cherry Leung","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Cherry Leung","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046072860","display_name":"Deena M.A. Gendoo","orcid":"https://orcid.org/0000-0001-8891-4138","observed_orcids":["https://orcid.org/0000-0001-8891-4138"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Deena M.A. Gendoo","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034320116","display_name":"Evelyne Lima\u2010Fernandes","orcid":"https://orcid.org/0000-0002-3628-9745","observed_orcids":["https://orcid.org/0000-0002-3628-9745"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Evelyne Lima-Fernandes","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113447946","display_name":"Antonija Kreso","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Antonija Kreso","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065120058","display_name":"Robin Wolman","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Robin Wolman","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072341399","display_name":"EVA M. SZENTGYORGYI","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Eva Szentgyorgyi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016850642","display_name":"Douglass C. Vines","orcid":"https://orcid.org/0000-0001-7560-1079","observed_orcids":["https://orcid.org/0000-0001-7560-1079"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Douglass C. Vines","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010487226","display_name":"Benjamin Haibe\u2010Kains","orcid":"https://orcid.org/0000-0002-7684-0079","observed_orcids":["https://orcid.org/0000-0002-7684-0079"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Benjamin Haibe-Kains","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033385547","display_name":"Bradly G. Wouters","orcid":"https://orcid.org/0000-0002-8187-592X","observed_orcids":["https://orcid.org/0000-0002-8187-592X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Bradly G. Wouters","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065405706","display_name":"Ur Metser","orcid":"https://orcid.org/0000-0003-3726-8994","observed_orcids":["https://orcid.org/0000-0003-3726-8994"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ur Metser","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008048551","display_name":"David Anthony Jaffray","orcid":"https://orcid.org/0000-0001-7378-7543","observed_orcids":["https://orcid.org/0000-0001-7378-7543"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David A. Jaffray","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017804779","display_name":"Myles J. F. Smith","orcid":"https://orcid.org/0000-0002-3254-4817","observed_orcids":["https://orcid.org/0000-0002-3254-4817"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Myles Smith","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5078621860","display_name":"Catherine Adell O'Brien","orcid":"https://orcid.org/0000-0003-0682-3879","observed_orcids":["https://orcid.org/0000-0003-0682-3879"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Catherine A. O'Brien","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10631","display_name":"Cancer, Hypoxia, and Metabolism","score":0.4765999913215637,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10631","display_name":"Cancer, Hypoxia, and Metabolism","score":0.4765999913215637,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10336","display_name":"Cancer Cells and Metastasis","score":0.39309999346733093,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.05260000005364418,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/evofosfamide","display_name":"evofosfamide","score":0.984000027179718},{"id":"https://openalex.org/keywords/hypoxia-activated-prodrug","display_name":"hypoxia-activated prodrug","score":0.9610000252723694},{"id":"https://openalex.org/keywords/colorectal-cancer","display_name":"colorectal cancer","score":0.9750000238418579},{"id":"https://openalex.org/keywords/cancer-stem-cells","display_name":"cancer stem cells","score":0.9959999918937683},{"id":"https://openalex.org/keywords/tumor-hypoxia","display_name":"tumor hypoxia","score":0.8600000143051147},{"id":"https://openalex.org/keywords/5-fluorouracil","display_name":"5-fluorouracil","score":0.9570000171661377},{"id":"https://openalex.org/keywords/chemoradiotherapy","display_name":"chemoradiotherapy","score":0.9980000257492065},{"id":"https://openalex.org/keywords/sequential-therapy","display_name":"sequential therapy","score":0.746999979019165},{"id":"https://openalex.org/keywords/adjuvant-therapy","display_name":"adjuvant therapy","score":0.9710000157356262},{"id":"https://openalex.org/keywords/limiting-dilution-assay","display_name":"limiting dilution assay","score":0.7620000243186951},{"id":"https://openalex.org/keywords/hypoxia-markers","display_name":"hypoxia markers","score":0.6919999718666077}],"concepts":[{"id":"https://openalex.org/C108215921","wikidata":"https://www.wikidata.org/wiki/Q603741","display_name":"Prodrug","level":2,"score":0.7784123420715332},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.7343057990074158},{"id":"https://openalex.org/C7836513","wikidata":"https://www.wikidata.org/wiki/Q1641506","display_name":"Hypoxia (environmental)","level":3,"score":0.6683329343795776},{"id":"https://openalex.org/C2779081379","wikidata":"https://www.wikidata.org/wiki/Q7852677","display_name":"Tumor hypoxia","level":3,"score":0.6023389101028442},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5587279200553894},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5517758727073669},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.5401436686515808},{"id":"https://openalex.org/C2776999253","wikidata":"https://www.wikidata.org/wiki/Q1304270","display_name":"Combination therapy","level":2,"score":0.4583929777145386},{"id":"https://openalex.org/C2778424827","wikidata":"https://www.wikidata.org/wiki/Q5090613","display_name":"Chemoradiotherapy","level":3,"score":0.45387449860572815},{"id":"https://openalex.org/C509974204","wikidata":"https://www.wikidata.org/wiki/Q180507","display_name":"Radiation therapy","level":2,"score":0.4506807029247284},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.43334531784057617},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.433086097240448},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3997924327850342},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.2532893717288971},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.24532875418663025},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.18912780284881592},{"id":"https://openalex.org/C540031477","wikidata":"https://www.wikidata.org/wiki/Q629","display_name":"Oxygen","level":2,"score":0.0},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1158/1078-0432.c.6525963","doi":"https://doi.org/10.1158/1078-0432.c.6525963","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1078-0432.c.6525963","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"doi:10.1158/1078-0432.c.6525963.v1","doi":"https://doi.org/10.1158/1078-0432.c.6525963.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.c.6525963.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.c.6525963","doi":"https://doi.org/10.1158/1078-0432.c.6525963","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1078-0432.c.6525963","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9940000176429749}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2791469985","https://openalex.org/W4362402109","https://openalex.org/W4361926295","https://openalex.org/W4362432689","https://openalex.org/W2395554535","https://openalex.org/W4389397498","https://openalex.org/W2592091290","https://openalex.org/W2802609269","https://openalex.org/W4396733282","https://openalex.org/W3093601036"],"abstract_inverted_index":{"Abstract":[0],"Purpose:":[1],"Cancer-initiating":[2],"cells":[3,41,150],"(C-IC)":[4],"have":[5,38],"been":[6],"described":[7],"in":[8,87,120],"multiple":[9],"cancer":[10,77,149],"types,":[11],"including":[12],"colorectal":[13,76,110,148],"cancer.":[14],"C-ICs":[15,27],"are":[16],"defined":[17],"by":[18,47,117,176,223],"their":[19],"capacity":[20],"to":[21,31,42,70,133,141,163,209,218,244],"self-renew,":[22],"thereby":[23],"driving":[24],"tumor":[25,181],"growth.":[26],"were":[28,79,115,154],"initially":[29],"thought":[30],"be":[32,43],"static":[33],"entities;":[34],"however,":[35],"recent":[36],"studies":[37],"determined":[39],"these":[40],"dynamic":[44],"and":[45,95,103,147,157],"influenced":[46],"microenvironmental":[48],"cues":[49],"such":[50],"as":[51,129,232,234,239],"hypoxia.":[52,136],"If":[53],"hypoxia":[54,64,201,243],"drives":[55],"the":[56,109,143,195,220,235],"formation":[57,144],"of":[58,63,145,183,205,237],"C-ICs,":[59],"then":[60],"therapeutic":[61],"targeting":[62],"could":[65],"represent":[66],"a":[67,83,130,160,206,215,225,240],"novel":[68,161,216],"means":[69,217],"target":[71,219],"C-ICs.":[72],"Experimental":[73],"Design:":[74],"Patient-derived":[75],"xenografts":[78,184],"treated":[80],"with":[81,89,171,186],"evofosfamide,":[82],"hypoxia-activated":[84],"prodrug":[85],"(HAP),":[86],"combination":[88,164],"5-fluorouracil":[90],"(5-FU)":[91],"or":[92,173,188],"chemoradiotherapy":[93],"(5-FU":[94],"radiation;":[96],"CRT).":[97],"Treatment":[98],"groups":[99],"included":[100],"both":[101],"concurrent":[102],"sequential":[104,169],"dosing":[105],"regimens.":[106],"Effects":[107],"on":[108],"cancer-initiating":[111],"cell":[112],"(CC-IC)":[113],"fraction":[114,222],"assessed":[116],"serial":[118],"passage":[119],"vivo":[121],"limiting":[122],"dilution":[123],"assays.":[124],"FAZA-PET":[125,200,238],"imaging":[126,202],"was":[127,139,203],"utilized":[128],"noninvasive":[131,199],"method":[132],"assess":[134],"intratumoral":[135],"Results:":[137],"Hypoxia":[138],"sufficient":[140],"drive":[142],"CC-ICs":[146],"surviving":[151],"conventional":[152,229],"therapy":[153],"more":[155],"hypoxic":[156],"C-IC-like.":[158],"Using":[159],"approach":[162],"therapy,":[165,231],"we":[166],"show":[167],"that":[168,247],"treatment":[170],"5-FU":[172,187],"CRT":[174,189],"followed":[175],"evofosfamide":[177],"not":[178],"only":[179],"inhibits":[180],"growth":[182],"compared":[185],"alone,":[190],"but":[191],"also":[192],"significantly":[193],"decreases":[194],"CC-IC":[196,221],"fraction.":[197],"Furthermore,":[198],"predictive":[204],"tumor's":[207],"response":[208],"evofosfamide.":[210],"Conclusions:":[211],"Our":[212],"data":[213],"demonstrate":[214],"adding":[224],"HAP":[226],"sequentially":[227],"after":[228],"adjuvant":[230],"well":[233],"use":[236],"biomarker":[241],"for":[242],"identify":[245],"tumors":[246],"will":[248],"benefit":[249],"most":[250],"from":[251],"this":[252],"approach.":[253],"Clin":[254],"Cancer":[255],"Res;":[256],"24(9);":[257],"2116\u201327.":[258],"\u00a92018":[259],"AACR.":[260]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-04-05T00:00:00"}